GlassScriptPhysician profile
Ronald A Volney
NPI 1720296098
$6,970.92
in general payments reported to CMS, 2019-2025
42 companies · $33.55 in 2025
The $33.55 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,517 · 2020: $1,075 · 2021: $1,582 · 2022: $1,576 · 2023: $1,171 · 2024: $15.66 · 2025: $33.55.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,221.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,220.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,193.99 | 2019-2024 | Vraylar, Ubrelvy, Linzess |
| Pfizer INC. | $907.94 | 2019-2023 | |
| Novo Nordisk INC | $550.52 | 2019-2023 | Wegovy, Rybelsus, Ozempic |
| Astrazeneca Pharmaceuticals LP | $534.93 | 2019-2025 | Farxiga |
| Glaxosmithkline, LLC. | $475.41 | 2019-2023 | Trelegy Ellipta |
| Arbor Pharmaceuticals, INC. | $298.52 | 2019-2022 | |
| Nestle Healthcare Nutrition INC. | $297.93 | 2020-2023 | |
| Janssen Pharmaceuticals, INC | $288.79 | 2020-2023 | Xarelto |
| Boehringer Ingelheim Pharmaceuticals, INC. | $276.92 | 2019-2022 | |
| Mylan Specialty L.P. | $175.91 | 2019-2023 | Yupelri |
| Novartis Pharmaceuticals Corporation | $173.56 | 2019-2023 | |
| Biodelivery Sciences International, INC. | $165.90 | 2020-2021 | |
| Lilly USA, LLC | $154.32 | 2019-2022 | |
| Allergan, INC. | $139.94 | 2019-2020 | |
| Kowa Pharmaceuticals America, INC. | $138.15 | 2019-2021 |
Show all 42 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ronald Volney listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.